Gil Roth12.16.13
Phase II
Alcobra posts adult ADHD results . . . read more
Alnylam begins subcutaneous ATTR treatment trial . . . read more
Initial results in for BioLineRx AML trial . . . read more
La Jolla begins CKD trial . . . read more
NeoStem completes enrollment in CV trial . . . read more
Phase III
Cubist posts topline results from cIAI trial . . . read more
Filings
Gilead Complera one-tab HIV regimen approved for new patient group . . . read more
PharmAthene trial placed on clinical hold . . . read more
Recipharm unit files infectious app . . . read more
Shield cleared for CKD trial . . . read more
Alcobra posts adult ADHD results . . . read more
Alnylam begins subcutaneous ATTR treatment trial . . . read more
Initial results in for BioLineRx AML trial . . . read more
La Jolla begins CKD trial . . . read more
NeoStem completes enrollment in CV trial . . . read more
Phase III
Cubist posts topline results from cIAI trial . . . read more
Filings
Gilead Complera one-tab HIV regimen approved for new patient group . . . read more
PharmAthene trial placed on clinical hold . . . read more
Recipharm unit files infectious app . . . read more
Shield cleared for CKD trial . . . read more